BALL MEMORIAL HOSPITAL
- Type
- Teaching hospital
- Where
- Muncie, IN
- Medicare CCN
- 150089
- Received
- $208,866 in 45 records, 2021 ($53,177 general, $155,688 research)
- Source
- CMS Open Payments search ↗
On this site
- Federal award recipient: BALL MEMORIAL HOSPITAL, INC. Fuzzy (name and state)
- Lobbying client: BALL MEMORIAL HOSPITAL Fuzzy (name and state)
- Lobbying client: BALL MEMORIAL HOSPITAL Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2021 | General payment | 7 | $53,177 |
| 2021 | Research payment | 38 | $155,688 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $63,145 | 2021 |
| AstraZeneca Pharmaceuticals LP | 6 | $57,259 | 2021 |
| Lilly USA, LLC | 1 | $50,000 | 2021 |
| LivaNova USA, Inc. | 7 | $12,325 | 2021 |
| CSL Behring | 4 | $8,918 | 2021 |
| Amgen Inc. | 3 | $8,205 | 2021 |
| Boston Scientific Corporation | 13 | $5,200 | 2021 |
| Medical Device Business Services, Inc. | 2 | $1,400 | 2021 |
| Central Admixture Pharmacy Services, Inc. | 1 | $764 | 2021 |
| FUJIFILM SonoSite, Inc. | 2 | $680 | 2021 |
| Travere Therapeutics, Inc. | 4 | $635 | 2021 |
| Johnson & Johnson Health Care Systems Inc. | 1 | $332 | 2021 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 38 | $155,688 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 1 | $50,000 |
| Space rental or facility fees (teaching hospital only) | 2 | $1,400 |
| Debt forgiveness | 2 | $1,097 |
| Education | 2 | $680 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | AstraZeneca Pharmaceuticals LP | $2,154 | Research payment | In-kind items and services | A Phase II Multicenter Open label Study to Evaluate the Efficacy and Safety of Trastuzumab Deruxtecan TDXd for the Treat | 2021 | |
| 2021-12-23 | LivaNova USA, Inc. | $485 | Research payment | Cash or cash equivalent | VNS - Vitaria Device, Cardiology/Vascular Diseases | ANTHEM HFrEF | 2021 |
| 2021-12-22 | LivaNova USA, Inc. | $1,780 | Research payment | Cash or cash equivalent | VNS - Vitaria Device, Cardiology/Vascular Diseases | ANTHEM HFrEF | 2021 |
| 2021-12-14 | Central Admixture Pharmacy Services, Inc. | $764 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-12-06 | Boston Scientific Corporation | $500 | Research payment | Cash or cash equivalent | VARIOUS RELEASED ICD FAMILIES Device, Clinical Trial Product | APPRAISE ATP | 2021 |
| 2021-12-06 | Boston Scientific Corporation | $51 | Research payment | Cash or cash equivalent | VARIOUS RELEASED ICD FAMILIES Device, Clinical Trial Product | APPRAISE ATP | 2021 |
| 2021-12-01 | LivaNova USA, Inc. | $7,000 | Research payment | Cash or cash equivalent | VNS - Vitaria Device, Cardiology/Vascular Diseases | ANTHEM HFrEF | 2021 |
| 2021-11-01 | Boston Scientific Corporation | $118 | Research payment | Cash or cash equivalent | VARIOUS RELEASED ICD FAMILIES Device, Clinical Trial Product | APPRAISE ATP | 2021 |
| 2021-10-04 | Boston Scientific Corporation | $51 | Research payment | Cash or cash equivalent | VARIOUS RELEASED ICD FAMILIES Device, Clinical Trial Product | APPRAISE ATP | 2021 |
| 2021-08-06 | FUJIFILM SonoSite, Inc. | $388 | Education | In-kind items and services | SonoSite Edge II Device, Medical Device | 2021 | |
| 2021-08-03 | Boston Scientific Corporation | $203 | Research payment | Cash or cash equivalent | VARIOUS RELEASED ICD FAMILIES Device, Clinical Trial Product | APPRAISE ATP | 2021 |
| 2021-07-21 | AstraZeneca Pharmaceuticals LP | $24,096 | Research payment | Cash or cash equivalent | A Phase II Multicenter Open label Study to Evaluate the Efficacy and Safety of Trastuzumab Deruxtecan TDXd for the Treat | 2021 | |
| 2021-07-20 | Medical Device Business Services, Inc. | $200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Carto 3 Device, Cardiology | 2021 | |
| 2021-06-30 | LivaNova USA, Inc. | $1,924 | Research payment | Cash or cash equivalent | VNS - Vitaria Device, Cardiology/Vascular Diseases | ANTHEM HFrEF | 2021 |
| 2021-06-24 | CSL Behring | $379 | Research payment | In-kind items and services | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2021 | |
| 2021-06-17 | AstraZeneca Pharmaceuticals LP | $1,190 | Research payment | Cash or cash equivalent | IMFINZI Biological, Oncology | A Non-Interventional Primary Data Collection Study to Assess the Prevalence of PD-L1 High in First Line Metastatic and L | 2021 |
| 2021-06-16 | LivaNova USA, Inc. | $165 | Research payment | Cash or cash equivalent | VNS - Vitaria Device, Cardiology/Vascular Diseases | ANTHEM HFrEF | 2021 |
| 2021-06-07 | CSL Behring | $4,000 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2021 | |
| 2021-05-21 | AstraZeneca Pharmaceuticals LP | $20,452 | Research payment | Cash or cash equivalent | A Phase 2 Study of TDXd in Patients With Selected HER2 Expressing Tumors | 2021 | |
| 2021-05-17 | Boston Scientific Corporation | $2,039 | Research payment | Cash or cash equivalent | SQRX Pulse Generator Device, Tachy | S ICD PAS | 2021 |
| 2021-05-17 | Boston Scientific Corporation | $624 | Research payment | Cash or cash equivalent | VARIOUS RELEASED ICD FAMILIES Device, Clinical Trial Product | APPRAISE ATP | 2021 |
| 2021-05-08 | FUJIFILM SonoSite, Inc. | $291 | Education | In-kind items and services | SonoSite Edge II Device, Medical Device | 2021 | |
| 2021-05-06 | Travere Therapeutics, Inc. | $500 | Research payment | Cash or cash equivalent | 021IGAN17001 | 2021 | |
| 2021-04-28 | AstraZeneca Pharmaceuticals LP | $6,866 | Research payment | Cash or cash equivalent | urvalumab+/- Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung C | 2021 | |
| 2021-04-23 | Amgen Inc. | $6,930 | Research payment | Cash or cash equivalent | GALACTIC - HF | 2021 | |
| 2021-04-09 | Medical Device Business Services, Inc. | $1,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Carto 3 Device, Cardiology | 2021 | |
| 2021-04-01 | Travere Therapeutics, Inc. | $45 | Research payment | Cash or cash equivalent | 021IGAN17001 | 2021 | |
| 2021-04-01 | Travere Therapeutics, Inc. | $45 | Research payment | Cash or cash equivalent | 021IGAN17001 | 2021 | |
| 2021-04-01 | Travere Therapeutics, Inc. | $45 | Research payment | Cash or cash equivalent | 021IGAN17001 | 2021 | |
| 2021-03-17 | Johnson & Johnson Health Care Systems Inc. | $332 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-03-15 | Boston Scientific Corporation | $660 | Research payment | Cash or cash equivalent | SQRX Pulse Generator Device, Tachy | S ICD PAS | 2021 |
| 2021-03-15 | Boston Scientific Corporation | $236 | Research payment | Cash or cash equivalent | VARIOUS RELEASED ICD FAMILIES Device, Clinical Trial Product | APPRAISE ATP | 2021 |
| 2021-03-05 | AstraZeneca Pharmaceuticals LP | $2,500 | Research payment | Cash or cash equivalent | Study of Durvalumab Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have | 2021 | |
| 2021-03-03 | LivaNova USA, Inc. | $334 | Research payment | Cash or cash equivalent | VNS - Vitaria Device, Cardiology/Vascular Diseases | ANTHEM HFrEF | 2021 |
| 2021-02-24 | LivaNova USA, Inc. | $635 | Research payment | Cash or cash equivalent | VNS - Vitaria Device, Cardiology/Vascular Diseases | ANTHEM HFrEF | 2021 |
| 2021-02-23 | CSL Behring | $539 | Research payment | In-kind items and services | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2021 | |
| 2021-02-15 | Boston Scientific Corporation | $76 | Research payment | Cash or cash equivalent | SQRX Pulse Generator Device, Tachy | S ICD PAS | 2021 |
| 2021-02-04 | CSL Behring | $4,000 | Research payment | Cash or cash equivalent | A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a | 2021 | |
| 2021-01-25 | Lilly USA, LLC | $50,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2021 | ||
| 2021-01-22 | Amgen Inc. | $275 | Research payment | In-kind items and services | Neulasta Biological, Oncology | Prospective Observational Study of Onpro vs SOC. | 2021 |
| 2021-01-20 | Novartis Pharmaceuticals Corporation | $63,145 | Research payment | Cash or cash equivalent | ENTRESTO Drug, CARDIOVASCULAR | PROSPECTIVE COMPARISON OF ARNI WITH ARB GIVEN FOLLOWING STABILIZATION IN DECOMPENSATED HFPEF (PARAGLIDE-HFPEF) | 2021 |
| 2021-01-20 | Amgen Inc. | $1,000 | Research payment | Cash or cash equivalent | Neulasta Biological, Oncology | Prospective Observational Study of Onpro vs SOC. | 2021 |
| 2021-01-19 | Boston Scientific Corporation | $500 | Research payment | Cash or cash equivalent | VARIOUS RELEASED ICD FAMILIES Device, Clinical Trial Product | APPRAISE ATP | 2021 |
| 2021-01-19 | Boston Scientific Corporation | $85 | Research payment | Cash or cash equivalent | SQRX Pulse Generator Device, Tachy | S ICD PAS | 2021 |
| 2021-01-19 | Boston Scientific Corporation | $51 | Research payment | Cash or cash equivalent | VARIOUS RELEASED ICD FAMILIES Device, Clinical Trial Product | APPRAISE ATP | 2021 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Muncie, IN, county Delaware County, IN, state Indiana; placed by its city name.
| Measure | Place (city or town) Muncie, IN | County Delaware County, IN | State Indiana |
|---|---|---|---|
| Population B01003 | 64,751 | 112,280 | 6,851,073 |
| Population, 2020 census P1 | 65,194 | 111,903 | 6,785,528 |
| Median age B01002 | 29.7 | 35.8 | 38.1 |
| Under 18 B01001 | 15.8% | 18.1% | 23.3% |
| 65 and over B01001 | 14.3% | 17.6% | 16.8% |
| Households B11001 | 26,479 | 46,256 | 2,716,009 |
| Foreign born B05002 | 3.3% | 2.5% | 6.3% |
| Median household income B19013 | $44,471 | $58,127 | $71,957 |
| Median family income B19113 | $60,880 | $74,407 | $90,767 |
| Per capita income B19301 | $25,281 | $31,091 | $38,351 |
| Poverty rate B17001 | 29.2% | 19.6% | 12.3% |
| Unemployment rate B23025 | 7.8% | 5.8% | 4.3% |
| Civilian labor force B23025 | 32,546 | 56,486 | 3,472,016 |
| Mean commute (minutes) B08013 | 18.1 | 21.2 | 24.1 |
| Bachelor's degree or higher B15003 | 26.1% | 26.2% | 29.5% |
| Housing units B25001 | 30,715 | 51,635 | 2,976,568 |
| Owner-occupied B25003 | 52.0% | 66.5% | 70.6% |
| Renters B25003 | 48.0% | 33.5% | 29.4% |
| Median home value B25077 | $97,300 | $139,400 | $218,200 |
| Median gross rent B25064 | $904 | $906 | $1,062 |
| White, not Hispanic B03002 | 78.4% | 84.3% | 75.4% |
| Black B03002 | 8.1% | 5.2% | 9.1% |
| Hispanic or Latino B03002 | 4.4% | 3.3% | 8.6% |
| Asian B03002 | 2.1% | 1.6% | 2.6% |
| American Indian and Alaska Native B03002 | 0.2% | 0.1% | 0.1% |
Economy now FRED unemployment 3.4% in Sep 2026 (3.7% a year earlier); per capita personal income $66,455 in 2025, up 28% in five years (+3.2% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Muncie, IN.
Comments